Approvals/CIMA-AEMPS/LETROZOL AUROVITAS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

LETROZOL AUROVITAS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Eugia Pharma (Malta) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 062c8b769420d5d2
Drug Cima Aemps Name: LETROZOL AUROVITAS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 85626
Holder Company Name: Eugia Pharma (Malta) Limited
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2020-12-30
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 2,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Eugia Pharma (Malta) Limited

LETROZOL

2,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 30, 2020

Approval ID

062c8b769420d5d2

Type

Standard